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Abstract
Background: In the ‘Tailored Implementation for Chronic Diseases (TICD)’ project, five tailored implementation
programs to improve healthcare delivery in different chronic conditions have been developed. These programs will
be evaluated in distinct cluster-randomized controlled trials. This protocol describes the process evaluation across
these trials, which aims to identify determinants of change in chronic illness care, to examine the validity of the
tailoring methods that were applied, and to analyze the association of implementation activities and the
effectiveness of the program.
Methods: A multilevel approach was used to develop five tailored implementation interventions. In order to guide
the process evaluation in five distinct trials, the study protocols for the cluster randomized trials and the related
process evaluations were developed simultaneously and iteratively.
Results: The process evaluation comprises three main components: a structured survey with health professionals in
the trials, semi-structured interviews with a purposeful sample of this study population, and standardized documentation
of organizational practice characteristics. Norway will only conduct the qualitative part of the analysis because the
survey and documentation of practice characteristics are considered to be not feasible. The evaluation is guided
by ‘logic models’ of the implementation programs: frameworks that specify the linkages between the strategies
used, the determinants addressed by tailoring, and the anticipated outcomes. Standardization of measures across
trials is sought to facilitate analysis of aggregated data from the trials.
Conclusions: This process evaluation will need to find a balance between standardization of methods across trials
and the tailoring of measures to the specificities of each trial.
Keywords: process evaluation, tailored implementation intervention, chronic illness care
Background
‘Tailored interventions’ are commonly defined as inter-
ventions that are designed to address previously identi-
fied determinants of practice (also called ‘barriers to and
enablers of change’) [1]. A range of different methods
has been used for tailoring, but there is little insight into
how tailoring is best conducted in order to optimize the
effectiveness of interventions [2]. The overall aim of the
‘Tailored Implementation for Chronic Disease (TICD)’
project is to provide insight into methods for tailoring
implementation programs to determinants of implemen-
tation of evidence-based healthcare for patients with
chronic illness [3]. Research teams from five European
countries participate in the TICD project, each focusing
on a specific clinical condition: chronic obstructive pul-
monary disease (COPD) in Poland, obesity in the United
Kingdom, cardiovascular diseases in The Netherlands,
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depression in the elderly in Norway, and multimorbidity
in Germany.
Addressing the identified determinants of practice in
chronic illness care requires complex interventions,
meaning interventions that have multiple components
which interact with each other. In the TICD project,
five tailored implementation interventions were devel-
oped, each of which will be evaluated in a cluster-
randomized trial [4-8].
A frequent criticism of evaluations of complex interven-
tions is their lack of detail in both description and analysis
on what components of the intervention and which con-
textual factors contributed to the (lack of) effectiveness
[9]. We planned process evaluations in the TICD trials
aiming to address this by exploring which factors are asso-
ciated with change [10,11]. This knowledge is essential for
understanding the potential causal mechanisms under-
lying the effectiveness of interventions as well as for en-
suring generalizability of intervention effectiveness across
populations and settings [12]. At the same time, this will
provide insight into the validity of tailoring methods that
were applied in earlier phases of the TICD project.
A factor of specific interest is the degree to which the
offered interventions were applied as planned by the par-
ticipants (depending on the context this has been labeled
‘fidelity’ or ‘integrity’ of the intervention [13]). This know-
ledge is important to draw valid conclusions about interven-
tion effectiveness and the underlying change mechanisms.
Potentially useful interventions may appear ineffective due
to low or mistaken application as compared to the original
plan [13]. On the other hand, low fidelity or integrity may
reflect the adaptation of interventions in the delivery
phase to optimize their effectiveness.
Here, we aim to describe the planned process evalua-
tions that are intended to answer the following questions:
1. To what extent did the practitioners or patients use
the various components of the planned intervention
programs?
2. What is the validity of the methods used to tailor
the implementation program to determinants of
practice?
3. Which factors are associated with effective
implementation of evidence-based practice in chronic
illness care, after use of a tailored implementation
program?
4. How consistent are the findings regarding the
previous questions across the five trials?
Methods
Tailoring concept within the Tailored Implementation for
Chronic Diseases project
The overall approach in the TICD project has been de-
scribed elsewhere [3] and is summarized here. As depicted
in Figure 1, the tailoring process in the TICD project is di-
vided into five phases. In the first phase, a checklist of de-
terminants of practice was developed to support the
design and evaluation of implementation strategies [14].
Additionally, each team identified evidence-based recom-
mendations and relevant literature for the targeted condi-
tions. In the second phase, determinants of practice were
identified in all countries. A combination of methods was
used for this purpose: brainstorming and group interviews
with health professionals, individual interviews with health
professionals and patients, and a written survey for health
professionals. The identified determinants were evaluated
Phase 2: Identification and
prioritization of determinants
Phase 3: Identification of
strategies addressing
determinants
Phase 4: Final selection of
strategies/design of an 
implementation program
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Tailoring at the patient level
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Figure 1 Tailoring process in Tailored Implementation for Chronic Diseases (TICD) projects.
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according to their plausible importance and the degree to
which they could be addressed in an intervention study.
In the third phase, different methods (open group inter-
views and structured group work with health care profes-
sionals, researchers and other stakeholders) were used
to identify strategies to overcome the identified barriers
for the specific recommendations. In the fourth phase,
the identified strategies were prioritized on the basis of
the criteria ‘feasibility’ and ‘assumed impact’. These four
phases have been conducted in all countries, and based
on this prior work, five tailored implementation inter-
ventions were elaborated, each of which will be evalu-
ated in a cluster randomized controlled trial [4-8]. In
the delivery phase, implementation interventions may
be adapted by adjusting interventions to individual or
practice-related factors.
Development of a process evaluation protocol
The study protocols for the cluster randomized trials
and the related process evaluations were developed sim-
ultaneously and iteratively, using email and telephone
conversations among research teams to provide feedback
and discuss controversial aspects. The project coordin-
ator monitored and protected the coherence of the pro-
tocols and their fit with the overall aims of the TICD
project.
Results
Logic models
To facilitate the measurement and analysis all TICD
implementation programs will be operationalized into
a ‘logic’ (or ‘explanatory’) model comprising an anticipated
model of change mechanisms based on the results of the
tailoring process of each implementation intervention.
These models describe the hypothesized linkages between
determinants, interventions, and outcomes (Figure 2).
Setting/target groups of the process evaluation
The intervention programs in the TICD project are situ-
ated in primary care settings and target physicians, nurses,
and patients and their relatives. The study population in
the process evaluation comprises the healthcare profes-
sionals of the intervention group, however implementation
activities (whether planned or not) will be documented in
the control arms as well.
Data collection
The process evaluation has three main items: a survey
with two components (A1 and A2), an interview study
(B), and documentation of practice characteristics (C).
A1 - Survey on perceived change of determinants of
practice
We will perform written surveys in participating health
professionals at the primary follow-up measurement in
the trials (except in the Norwegian trial, where this sur-
vey is considered to be not feasible). As the content of
the studies differs, we have developed a frame of the
questionnaire that needs to be adapted to the relevant
content (Table 1). The questionnaire lists the determi-
nants of practice, which were identified and prioritized
in an earlier phase of the TICD project (regardless of
whether they are addressed by the implementation pro-
gram), with the question to assess whether the program
successfully targeted them. A free text field is used to
identify other determinants that are lacking from this list
and are perceived to have major impact.
A2 - Survey to document implementation activities
The survey of participants also contains questions on
the actual implementation activities. We intend to rec-
ord the extent to which the target group used the of-
fered interventions and adaptions on it in the delivery
Figure 2 Logic model of Tailored Implementation for Chronic Diseases (TICD) implementation interventions.
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phase of the implementation programs. Table 2 shows the
frame of the questionnaire used in all studies to document
implementation activities. The design of the questionnaire
is based on a published framework [15], which distinguishes
four aspects of intervention fidelity:
1. Content - Was the content of the intervention delivered
as planned?
2. Duration - Was the intervention fully implemented
across the intended time period?
3. Frequency - Was the intervention conducted as
frequent as planned?
4. Coverage - Was the intervention applied to all
individuals in the targeted group?
For each implementation program the core compo-
nents will be specified. For each core component, con-
tent, duration, frequency and coverage will be recorded
in a structured way (Table 2). The content of the items
will be specific for the different trials. A free text field is
added to identify strategies that have been missed in the
tailoring process so far, allowing the evaluation of the
methods used for tailoring.
B - Interviews with health professionals of the intervention
group
The third component of the process evaluation comprises
of semi-structured interviews with participants in the
intervention arms of the trials. The face-to-face interviews
(or, alternatively, telephone interviews) will be done with a
purposive sample of health professionals. The exact phras-
ing of questions will differ across trials, but the following
interview format will serve as a starting point for all
interviews:
1. What made you participate in the project in the first
place? What where your reasons and what were
your expectations?
2. Did the implementation program help you to adhere
to the recommendations?
a. If yes, what components did you find helpful and
why?
b. If no, why not and what strategies would have
been more helpful?
3. Were there any other factors or developments
which made it difficult for you or helped you to
adhere to the recommendations? You can think of
changes in regional or national healthcare,
developments in the practice organization and team
or events in your life and work.
4. Having experienced the program, what would you
recommend for the future? You may think of further
development, wider implementation or perhaps research.
Interim analysis after 5 to 10 interviews will be done
to adapt the interview format and purposeful sampling
scheme as required.
C - Practice characteristics and other contextual factors
The success of an implementation program may be influ-
enced by factors, which cannot, or at least cannot easily,
be addressed, such as the structure of the health system,
Table 1 Scheme of a questionnaire to examine the
validity of the methods used for tailoring (A1)
Standardized list of
determinants (result of phase 2).
Please list all determinants, no
matter if they are intended to be
addressed by the implementation
program or not
Was this determinant
in your opinion clearly
addressed by the
implementation program?
Yes Partly No
Determinant 1 □ □ □
Determinant 2 □ □ □
…
Free text field: Can you think of other factors, not yet listed above?
Table 2 Questionnaire to document implementation activities (A2)
Yes Partly No
Intervention component 1: Please describe the intervention component in sufficient detail (specify content, duration, frequency, coverage if applicable)
Did you use this item as described in terms of duration? (if applicable) □ □ □
Did you use this item as described in terms of frequency? (if applicable) □ □ □
Did you use this item as described in terms of coverage? (if applicable) □ □ □
Did you find this item helpful for the implementation of the recommendation/to reach the targets? □ □ □
Did you adapt the content or format of this item in any way? If yes, please specify below! □ □ □
Intervention component 2: Please describe the intervention component in sufficient detail (specify content, duration, frequency, coverage if applicable)
… □ □ □
Comments:
Free text field: Can you think of other intervention components which might have been more helpful in order to improve the implementation of the
recommendations/to reach the targets?
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laws or the organizational structure of the targeted set-
tings [16]. The TICD studies are focused on primary care.
In four TICD studies a number of practice characteristics
will be recorded in both study arms (Table 3). This is not
feasible in the Norwegian study, where municipalities are
the unit of randomization. In Norway, information regard-
ing relevant characteristics of the municipalities and spe-
cialist health care that may modify the effectiveness of the
interventions will be collected instead.
Data analysis
We will use the following analytical approach to answer
the research questions addressed by this process evaluation:
1. Research question 1 - To what extent did the
practitioners or patients use the various components
of the planned intervention programs? and
2. Research question 2 - What is the validity of the
methods used to tailor the implementation program
to determinants of practice?In order to answer these
questions a descriptive analysis of qualitative and
quantitative data will be done separately in each
country. The descriptive analysis of questionnaires
will result in tables with frequency distributions. The
qualitative interviews will be transcribed verbatim in
the original languages. An iterative thematic analysis
will be done, involving two or more researchers in
order to identify key themes relevant for
implementation.
3. Research question 3 - Which factors are associated
with implementation of evidence-based practice
in chronic illness care, after use of a tailored
implementation program?
To answer this research question a summary
outcome measure will be constructed in each trial,
expressing professional performance by aggregating
items reflecting implementation of evidence-based
recommendations. This outcome will be standardized
and taken as dependent variable in a regression
analysis approach. The independent variables in this
model will be a limited number of questionnaire
items (to reduce chance capitalization), selected
according to hypothesis informed by relevant key
themes of the interviews. A special focus will be
given to the association between professional
performance and the questionnaire items concerning
the application and adaption of the implementation
program by the target group.
4. Research question 4 - How consistent are the findings
across the trials?
A meta-analysis of quantitative and a meta-ethnography
of qualitative data from all five studies will be
conducted.
A qualitative meta-ethnography will be conducted
using the data from the interviews. For this purpose
a description of subcategories with significant
quotations from all studies will be provided in
English. This material will be analyzed according to
the principles of Noblit and Hare’s reciprocal
translational analysis, which is recommended to be
used when analyzing studies with similar topics
[17,18]. The result of this analysis will be a set of
key themes relevant in all studies. Interviews will be
re-analyzed to explore how each single study
contributes to the overall key themes. In a last step
third order interpretation across the key themes will
be considered if supported by a ‘line of argument’
across all studies.
A quantitative meta-analysis will be conducted,
focused on the summary outcome measure in
Table 3 Practice characteristics determined in all Tailored Interventions for Chronic Diseases (TICD) studies (C)
1. What is the yearly attending population (number of different patients that contact the practice in one year)?
2. What is the number of contacts your practice has per week?
3. How many physicians are working in your practice? (full-time equivalent)
4. How much non-physician staff is working in your practice? (full-time equivalent)?
5. How many inhabitants live in the city where your practice is located? o <5,000
o >5,000 <20,000
o >20,000 <50,000
o >50,000
6. Do all physicians have access to medical guidelines in your practice? o yes o no
7. Is a recall system for follow-up of chronically ill patients used in your practice? o yes o no
8. Are the tasks in your practice clearly assigned to specific staff? o yes o no
9. Does your practice have regular team meetings? o yes o no
10. Did your practice set targets for quality improvement in the last 12 months? o yes o no
11. Has the principal target (regarding quality improvement) been met? o yes o no
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each trial, using the predictors that are identified
as result from the analysis for question 3. While
the items composing this aggregate outcome
obviously differ among the trials, the assumption
is that the resulting measures are reasonably
comparable to allow pooling. Based on hypotheses
derived from phase 1 and 2, individual data and/
or clustered data from all trials will be included
in a meta-regression analysis. This last step will
efficiently make use of the total number of cases
included across all studies and the shared
instruments as described in this protocol.
Conclusions
Process evaluation is essential to understand the effects
and to explore potential causal mechanisms of complex
interventions. The planned process evaluation in the TICD
project needs to find a balance between standardization of
methods across trials and adaptation of measures to the
specific characteristics of each trial. Despite obvious limi-
tations, such as heterogeneity and suboptimal statistical
power, we believe that the planned study will contribute
to our knowledge on determinants of change in chronic
illness care and methods for tailoring implementation
programs to barriers and facilitators of change.
Trial status
The trial is currently in the planning phase.
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